Phase II randomised discontinuation trial of the MET/VEGF...

British Journal of Cancer 2017 / 02 Vol. 116; Iss. 4

Phase II randomised discontinuation trial of the MET/VEGF receptor inhibitor cabozantinib in metastatic melanoma

Daud, Adil, Kluger, Harriet M, Kurzrock, Razelle, Schimmoller, Frauke, Weitzman, Aaron L, Samuel, Thomas A, Moussa, Ali H, Gordon, Michael S, Shapiro, Geoffrey I
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
116
Language:
english
Journal:
British Journal of Cancer
DOI:
10.1038/bjc.2016.419
Date:
February, 2017
File:
PDF, 860 KB
english, 2017
Conversion to is in progress
Conversion to is failed